Regenerative Medicine Primer

submitted by: WentzMR
Dr. Andre Terzic, from Mayo Clinic in Rochester, MN, and Director of the enterprise-wide Center for Regenerative Medicine reviews his article appearing in the July 2013 issue of Mayo Clinic Proceedings, regarding the upcoming forum dedicated to regenerative medicine and surgery. Across specialties, the emerging tools, principles, and practices of regenerative medicine are at the core of transforming healthcare. Available at:

Introduction to the Symposium on Regenerative Medicine

submitted by: WentzMR
Dr. Eric Matteson, Chair of the Division of Rheumatology at Mayo Clinic in Rochester, MN, discusses the Symposium on Regenerative Medicine launched with the July 2013 issue of Mayo Clinic Proceedings. This first-of-its-kind compendium on the developing field of regenerative medicine and surgery, presented by leading experts, highlights new vistas in treatment options for patients. Available at:

Expanded umbilical cord blood shortens perilous wait for transplant recovery

submitted by: mdanderson

A team led by MD Anderson researchers finds that growing cord blood stem cells on a bed of supportive cells in the lab results in faster establishment of a new blood supply in patients who receive blood stem cell transplants, reducing the time when patients lack white blood cells, platelets.

European Heart Journal - My Cardio Interview: Andreas Zeiher & Ulf Landmesser on stem cells

submitted by: OxfordJournals

Andreas Zeiher in conversation with Ulf Landmesser:
Stem cells - An Update

Obama Inauguration: A Positive Change in Federal Stem Cell Research Policies

submitted by: CIRMTV
On March 9, 2009, President Barack Obama signed an executive order to lift a ban on federal funding for embryonic stem cell research that had been in place since August, 2001. In this video, Susan Fisher, director of the UCSF Human Embryonic Stem Cell Center, and Alan Trounson, president of the California Institute for Regenerative Medicine, discuss how the federal ban affected stem cell researchers and how President Obama's stem cell research policies will bring new opportunities in this...

Jerome Zack Talks About Creating iPS Cells

submitted by: CIRMTV
In 2006 scientists learned how to create a pluripotent stem cell out of a human skin cell. These cells, called induced pluripotent stem (iPS) cells have many of the characteristics of embryonic stem cells including the ability to create mature cell types. Dr. Jerome Zack has a CIRM grant to create iPS cells that could be used in human therapies. Zack is Associate Director, UCLA AIDS Institute, professor of Medicine, Microbiology, Immunology & Molecular Genetics, and a scientist with the...

Alan Lewis: Embryonic Stem Cell Therapies for Diabetes

submitted by: CIRMTV

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.

Mark Mercola: Differentiating Embryonic Stem Cells into Adult Tissues

submitted by: CIRMTV
A major challenge in developing stem cell-based cures for disease is maturing those cells into adult cell types that can be used for transplantation or to study human disease. Mark Mercola has a CIRM grant to derive heart muscle cells from embryonic stem cells. In this video, Dr. Mercola describes how stem cells could one day be used for transplantation, for testing new drugs for side effects on heart muscle cells, and to learn about how the heart cells mature and develop. That knowledge...

Stem Cells: Biology and Promise for Regenerative Medicine: Part 2: Tapping the Potential of Adult Stem Cells (1:17:03)

submitted by: scivee-team
Stem cells have both the capacity to self-renew, that is, to divide and create additional stem cells, and also to differentiate along a specified molecular pathway. Embryonic stem cells are very nearly totipotent, reserving the elite privileges of choosing among most if not all of the differentiation pathways that specify the animal. In contrast, stem cells that reside within an adult organ or tissue have more restricted options, often able to select a differentiation program from only a few...

Control and Regulation of Stem Cells with Leonard Zon Interviewed by Catherine Cormier

Dr. Leonard Zon is internationally recognized for his pioneering work in the fields of stem cell biology and cancer genetics. He received his MD from Jefferson Medical College, Philadelphia. He is founder and former president of the International Society for Stem Cell Research and chair of the Executive Committee of the newly formed Harvard Stem Cell Institute (HSCI). In 2005, Dr. Zon was elected to the Institute of Medicine of the National Academies. He recently completed a term as...